Derivatives n- (pheny (pyrrolidin-2-yl) methyl) benzamide and n - ((azepan-2-yl) phenylmethyl) benzamide, its preparation and its use in therapy.

Compound corresponding to the general formula (I): wherein n represents the number 1 or 3, R1 represents either a hydrogen atom, either a C1-C7 linear or branched alkyl optionally substituted with one or more fluorine atoms, While a C3-C7 group, or a (C3-C7) cycloalkyl-C1-C3 alkyl group, or a phenyl-C1-C3 alkyl optionally substituted with one or two methoxy groups, either a C2-C4 alkenyl group, or either a C2-C4 alkynyl group; X represents either a hydrogen atom or one or more substituents chosen from halogen atoms and the trifluoromethyl, C1-C6 alkoxy C1-C6 linear or branched, R2 represents either a hydrogen atom, or one or more substituents chosen from halogen atoms, and C6 C1-trifluoromethyl groups, C1-C6 alkyl, C1-C6 linear or branched, cycloalkyl C3-C7, phenyl, cyano, acetyl, benzoyl, S-alkyl C1-C6, ( ) alkyl-sulfonyl, carboxy and (C1-C6) alkoxy-carbonyl, bienun group of general formula NR3R4, SO2NR3R4 or CONR3R4, in which R3 and R4 each represent, independently of each other, a hydrogen atom or a group C1-C6 linear or branched or C3-C7 alkyl, or form, with the nitrogen atom carrying them, a pyrrolidinium cycle, piperidinium or morpholinium. in the form of base or of acid addition salt.